T1225 1.5%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T1225 1.5%, covering 2006-07-27 to 2006-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [Phase 3]